Authors: LLOYD GK MENZAGHI F BONTEMPI B SUTO C SIEGEL R AKONG M STAUDERMAN K VELICELEBI G JOHNSON E HARPOLD MM RAO TS SACAAN AI CHAVEZNORIEGA LE WASHBURN MS VERNIER JM COSFORD NDP MCDONALD LA

Citation: Gk. Lloyd et al., THE POTENTIAL OF SUBTYPE-SELECTIVE NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR AGONISTS AS THERAPEUTIC AGENTS, Life sciences, 62(17-18), 1998, pp. 1601-1606

Authors: STAUDERMAN KA MAHAFFY LS AKONG M VELICELEBI G CHAVEZNORIEGA LE CRONA JH JOHNSON EC ELLIOTT KJ GILLESPIE A REID RT ADAMS P HARPOLD MM COREYNAEVE J

Citation: Ka. Stauderman et al., CHARACTERIZATION OF HUMAN RECOMBINANT NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR SUBUNIT COMBINATIONS ALPHA-2-BETA-4, ALPHA-3-BETA-4 AND ALPHA-4-BETA-4 STABLY EXPRESSED IN HEK293 CELLS, The Journal of pharmacology and experimental therapeutics, 284(2), 1998, pp. 777-789

Authors: DAGGETT LP SACAAN AI AKONG M RAO SP HESS SD LIAW C URRUTIA A JACHEC C ELLIS SB DREESSEN J KNOPFEL T LANDWEHRMEYER GB TESTA CM YOUNG AB VARNEY M JOHNSON EC VELICELEBI G

Citation: Lp. Daggett et al., MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF RECOMBINANT HUMAN METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPE-5, Neuropharmacology, 34(8), 1995, pp. 871-886